UPDATE : Tuesday, July 7, 2020
상단여백
Celltrion tops pharmaceutical brand reputation in June
Celltrion ranked the first in the local brand reputation of listed pharmace...
by Park Gi-taek  |  2020-06-26 15:23
라인
10 more Korean drugmakers nestle in Boston to enter US market
Ten Korean pharmaceutical companies have additionally settled in the Cambri...
by Kim chan-hyuk  |  2020-06-26 14:12
라인
Alteogen signs $3.8-billion tech transfer deal with a global pharma
Alteogen has signed a $3.87 billion tech transfer contract with a global ph...
by Shim Hyun-tai  |  2020-06-25 16:19
라인
‘Use NEWS score system to detect high-risk Covid-19 patients early’
To reduce deaths caused by Covid-19 without treatment and vaccine, it is es...
by Song Soo-youn  |  2020-06-25 15:07
라인
Hanmi, Novartis in patent dispute over diabetes drug
A court is to decide on the legal dispute between Hanmi Pharmaceutical and ...
by Kim Yun-mi  |  2020-06-25 13:59
라인
Hanmi Science Presents 6 Great Visions for Post COVID-19
Hanmi Science with the gene of 'Innovation' presented six great vis...
by Lee Han-soo  |  2020-06-24 18:02
라인
GSK sure about Dovato’s changing HIV treatment paradigm
GSK is pioneering a new field in the human immunodeficiency virus (HIV) mar...
by Lee Han-soo  |  2020-06-24 12:11
라인
Hanmi to sell prostatism drug in Japan
Hanmi Pharmaceutical said Tuesday that it would release 2.5- and 5- milligr...
by Shim Hyun-tai  |  2020-06-23 18:17
라인
[News Focus] Pfizer Korea's restructuring enters into last-minute tug-of-war with union
The unionized workers of Upjohn Korea, a spinoff of Pfizer Korea's esta...
by Lee Han-soo  |  2020-06-23 16:51
라인
Labor-management dispute runs deep at MSD Korea
The conflict between unionized workers and management at MSD Korea is inten...
by Kim Yun-mi  |  2020-06-23 12:06
라인
‘Pfizer’s Vyndaqel, Vyndamax do not deserve rare disease pricing’
Pfizer’s Vyndaqel and Vyndamax -- containing tafamidis to treat cardiomyopa...
by Kim Yun-mi  |  2020-06-22 17:19
라인
New diabetes drug Steglatro fails to prove cardiovascular benefit
Steglatro (ingredient: ertugliflozin), the latecomer sodium-glucose co-tran...
by Kim Yun-mi  |  2020-06-19 14:55
라인
Yuyu to export SD Biosensor's Covid-19 test kit
Yuyu Pharmaceutical and SD Biosensor said they would cooperate in exporting...
by Lee Han-soo  |  2020-06-19 14:48
라인
HK inno.N nabs FDA nod for trial of gastric acid blocker
HK inno.N, formerly known as CJ Healthcare, said that the U.S. Food and Dru...
by Lee Han-soo  |  2020-06-18 17:39
라인
AZ’s Imfinzi wins extra indication for small-cell lung cancer
AstraZeneca’s immunotherapy Imfinzi (ingredient: durvalumab) has obtained l...
by Kim Yun-mi  |  2020-06-18 15:55
라인
5 key factors in successful secondary packaging and device assembly strategy
In his book The 7 Habits of Highly Effective People, Dr. Steven R. Covey of...
by Lee Han-soo  |  2020-06-18 15:52
라인
Lilly beats Pfizer in treating early breast cancer
Pfizer was the first to release a drug for the treatment of hormone recepto...
by Kim Yun-mi  |  2020-06-18 14:44
라인
‘Tecentriq, major turning point for triple-negative breast cancer treatment’
Roche Korea’s Tecentriq, the first immunotherapy to win indication for trip...
by Kim Yun-mi  |  2020-06-18 14:43
라인
IOF aims to reduce osteoporosis-related fractures by 25% by 2025
The International Osteoporosis Foundation, a non-governmental organization ...
by Kim Yun-mi  |  2020-06-17 14:28
라인
JW Pharma to recreate its anticancer therapy as Covid-19 drug
JW Pharmaceutical said Wednesday that it would reposition CWP291, its antic...
by Shim Hyun-tai  |  2020-06-17 14:26
여백
여백
여백
Back to Top